Navigation Links
Dr. Yu Yamaguchi named recipient of the Humanitarian Scientific Achievement Award
Date:10/25/2007

Burnham Institute for Medical Research Professor Yu Yamaguchi, M.D., Ph.D., was recently awarded The Humanitarian Scientific Achievement Award by the MHE Research Foundation. The focus of the foundation is to find a cure for Multiple Hereditary Exostoses, a rare genetic bone disorder. The disorder causes people to grow exostoses (bone tumors) on their bones. MHE patients can also suffer from non-skeletal medical issues including mental and neurological issues. At this time, there is no treatment or cure. Surgery, physical therapy and pain management are currently the only options in management of the condition.

Mutations in a gene known as EXT1 cause MHE. Dr. Yamaguchi created a mouse model, in which the EXT1 gene can be experimentally disrupted in tissues and organs of interest. His research has provided insights into why MHE patients suffer from non-skeletal medical problems. Dr. Yamaguchi has recently shown that mutations in the EXT1 gene can cause dysfunction of nerve cells, providing a clue as to why MHE patients sometimes associate mental and neurological symptoms. Today, the mouse model is being used in more than 20 laboratories around the world, helping researchers explore the function of the EXT1 gene in a variety of organs and tissues.

Dr. Yu Yamaguchi has expanded the frontiers of understanding of MHE, said Sarah Ziegler, MHE Research Foundation Vice President. These insights also suggest potential novel approaches that can be explored in order to make the dream of a treatment into a reality. Ziegler is also the mother of a son with MHE.

A crystal plaque commemorating the award was presented to Dr. Yamaguchi during the Foundation's FUNTASIA Research Banquet held on September 30, 2007 in Brooklyn, New York. Dr. Yamaguchi was also presented citations and proclamations from U.S. Congress, New York State Senate, and the Borough of Brooklyn.


'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
6. Kidney Donors Health Can Cause Anxiety Among Kidney Recipients
7. Kidney transplant donor and recipients need to talk it out
8. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
9. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
10. TNF Protein Can Predict GVHD Bone Marrow Transplant Recipients
11. Kidney Transplant Recipients Tardy In Taking Vital Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: